Topics / Health Services

A subject heading for parliamentary questions

Health Services

2,809 questions from 142 TDs, between 22 January 2025 and 22 October 2026.

2,809
questions
2,798 written, 11 oral
142
TDs have asked
11
parties and groups
Independents counted together
7
departments asked

Questions per month

The record holds no questions for August, when the Dáil does not sit.

Jan 2025Oct 2026
Show as a table
MonthQuestions
January 202556
February 202578
March 202573
April 2025110
May 2025158
June 2025127
July 2025135
August 20250
September 2025193
October 202556
November 2025157
December 2025147
January 2026238
February 2026102
March 2026141
April 2026243
May 2026222
June 2026290
July 2026123
August 20260
September 202673
October 202687

Who asks, by party

The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.

  • 100% RDR9 from 1 TD · 1 seat today
  • Aontú75 from 2 TDs · 2 seats today
  • Fianna Fáil616 from 33 TDs · 48 seats today
  • Fine Gael281 from 23 TDs · 38 seats today
  • Green Party16 from 1 TD · 1 seat today
  • Independent166 from 14 TDs · 15 seats today
  • Independent Ireland421 from 4 TDs · 4 seats today
  • Labour Party222 from 11 TDs · 11 seats today
  • People Before Profit-Solidarity85 from 3 TDs · 3 seats today
  • Sinn Féin676 from 38 TDs · 39 seats today

The TDs who asked most

Members of the Government answer questions rather than ask them. Each question counts once.

  1. 407
  2. 140
  3. 137
  4. 101
  5. 79
  6. 78
  7. 53
  8. 49

Asked of

Debated under the same heading

Debates whose official heading is exactly these words.

The questions

Ken O'Flynn Written 14 Apr 2026 · to Health
2704. Deputy Ken O'Flynn asked the Minister for Health whether she accepts that the absence of a national policy, standardised definitions, and centralised data collection in respect of elective procedures without clear medical indication represents a failure of governance and oversight within the public health system. [23884/26]
Ken O'Flynn Written 14 Apr 2026 · to Health
2705. Deputy Ken O'Flynn asked the Minister for Health the specific steps she will take to introduce a national policy framework governing the authorisation, funding, and clinical governance of such procedures. [23885/26]
Ken O'Flynn Written 14 Apr 2026 · to Health
2706. Deputy Ken O'Flynn asked the Minister for Health to confirm whether her Department requires the HSE to collect, report, and publish data on the allocation of theatre capacity to procedures which cannot currently be categorised as medically necessary. [23886/26]
Ken O'Flynn Written 14 Apr 2026 · to Health
2707. Deputy Ken O'Flynn asked the Minister for Health to detail the mechanisms in place, if any, to ensure consistency of decision-making across the six health regions in the absence of national policy. [23887/26]
Ken O'Flynn Written 14 Apr 2026 · to Health
2708. Deputy Ken O'Flynn asked the Minister for Health to outline how she satisfies herself that public resources are being allocated appropriately where the State cannot currently define, measure, or audit such activity. [23888/26]
Ken O'Flynn Written 14 Apr 2026 · to Health
2710. Deputy Ken O'Flynn asked the Minister for Health whether her Department maintains a national policy or framework governing the inspection, reporting, and oversight of environmental, hygiene, ventilation, and patient-safety conditions in oncology treatment facilities within the public health system; if so, the statutory or administrative basis for such a framework, the bodies responsible for carrying out inspect…
Ken O'Flynn Written 14 Apr 2026 · to Health
2711. Deputy Ken O'Flynn asked the Minister for Health to specify the categories of data, reports, or metrics her Department requires from the HSE or other bodies in relation to environmental conditions, infection prevention, ventilation adequacy, and patient safety in oncology treatment settings; to confirm whether such data is collected on a standardised national basis and reported to her Department at defined inte…
Ken O'Flynn Written 14 Apr 2026 · to Health
2712. Deputy Ken O'Flynn asked the Minister for Health the governance structures through which her Department satisfies itself that consistent environmental, hygiene, and patient-safety standards are applied across all public oncology treatment facilities; to detail the roles and responsibilities of her Department, the HSE, and any other relevant bodies in establishing, monitoring, and enforcing such standards; to co…
Ken O'Flynn Written 14 Apr 2026 · to Health
2713. Deputy Ken O'Flynn asked the Minister for Health to detail the audit, inspection, or compliance mechanisms currently in place to assess adherence to environmental, hygiene, ventilation, and patient-safety standards in oncology treatment facilities; to specify whether such audits are conducted on a routine, risk-based, or ad hoc basis; to confirm whether the findings of such audits are reported to her Department…
Ken O'Flynn Written 14 Apr 2026 · to Health
2714. Deputy Ken O'Flynn asked the Minister for Health whether her Department has conducted any review or assessment of the adequacy of current governance, inspection, and reporting arrangements in respect of environmental and patient-safety conditions in oncology treatment facilities; if so, to provide details of such reviews, including findings, recommendations, and implementation status; if not, whether she will c…
Ken O'Flynn Written 14 Apr 2026 · to Health
2715. Deputy Ken O'Flynn asked the Minister for Health the financial control framework governing expenditure under the treatment abroad scheme, including any cost ceilings, per-patient expenditure thresholds, or approval limits that apply to high-cost treatments funded outside the State; to specify the administrative or managerial grade within the HSE or Department required to approve such expenditure; and to confirm…
Ken O'Flynn Written 14 Apr 2026 · to Health
2716. Deputy Ken O'Flynn asked the Minister for Health to detail the audit and review mechanisms in place to assess expenditure under the treatment abroad scheme, including the frequency of internal audit, any involvement of the Comptroller and Auditor General, and whether any programme-level evaluations have been conducted since 2020; and to outline how value for money is assessed in circumstances where treatment is…
Ken O'Flynn Written 14 Apr 2026 · to Health
2717. Deputy Ken O'Flynn asked the Minister for Health to confirm whether her Department or the HSE maintains a consolidated dataset on expenditure under the treatment abroad scheme, including total annual spend, number of patients funded, and average cost per case; to specify whether such data is routinely reported to her Department; and to state whether there are plans to publish this information in a standardised …
Ken O'Flynn Written 14 Apr 2026 · to Health
2718. Deputy Ken O'Flynn asked the Minister for Health the policy position in respect of the collection and classification of expenditure under the treatment abroad scheme by treatment category; to confirm whether the absence of category-level data reflects a policy decision or a systems limitation; and to outline any steps being taken to introduce structured data collection to support oversight, audit, and policy ev…
Ken O'Flynn Written 14 Apr 2026 · to Health
2719. Deputy Ken O'Flynn asked the Minister for Health to clarify the governance framework that applies to expenditure under the treatment abroad scheme, including whether the Public Spending Code formally applies to individual funding decisions and programme-level oversight; and to set out how her Department satisfies itself that expenditure under the Scheme meets the standards of regularity, propriety, and value fo…
Ken O'Flynn Written 14 Apr 2026 · to Health
2720. Deputy Ken O'Flynn asked the Minister for Health the mechanisms in place to assess, challenge, or verify the costs charged by healthcare providers in other jurisdictions under the treatment abroad scheme; to confirm whether the State has any capacity to benchmark or negotiate such costs; and to set out how she mitigates the financial exposure arising from reliance on externally determined pricing structures. [2…
Ken O'Flynn Written 14 Apr 2026 · to Health
2721. Deputy Ken O'Flynn asked the Minister for Health whether any formal, written eligibility criteria exist governing the approval of funding under the treatment abroad scheme for procedures not available within the State, including gender-related surgical procedures; if such criteria exist, to provide the date of their introduction, the authority under which they were approved, and the body responsible for maintai…
Ken O'Flynn Written 14 Apr 2026 · to Health
2722. Deputy Ken O'Flynn asked the Minister for Health the definition of “clinical necessity” applied in the context of approvals under the treatment abroad scheme to specify whether this definition is standardised at national level or determined on a case-by-case basis by referring clinicians; and to confirm whether any national guidance, protocol, or decision-support framework exists to ensure consistency in the ap…
Ken O'Flynn Written 14 Apr 2026 · to Health
2723. Deputy Ken O'Flynn asked the Minister for Health to detail the decision-making and approval process for applications under the treatment abroad scheme; to specify the roles of referring consultants, multidisciplinary teams, the HSE, and any central approval authority in determining whether funding is granted; and to confirm whether final approval decisions are subject to independent clinical or administrative r…
Ken O'Flynn Written 14 Apr 2026 · to Health
2724. Deputy Ken O'Flynn asked the Minister for Health to outline the audit, review, and oversight mechanisms in place in respect of approvals granted under the Treatment Abroad Scheme; to confirm whether any audits have been conducted specifically examining the appropriateness, consistency, and value for money of approvals for procedures not available within the State; and if so, to provide the dates and findings of…
Ken O'Flynn Written 14 Apr 2026 · to Health
2725. Deputy Ken O'Flynn asked the Minister for Health the mechanisms in place to ensure consistency of decision-making across the six HSE health regions in respect of applications to the Treatment Abroad Scheme; to confirm whether any central monitoring, benchmarking, or variance analysis is carried out to identify differences in approval rates or referral patterns between regions; and if not, whether she accepts th…
Ken O'Flynn Written 14 Apr 2026 · to Health
2726. Deputy Ken O'Flynn asked the Minister for Health to confirm whether the HSE collects and maintains a centralised dataset in respect of approvals granted under the Treatment Abroad Scheme; to specify the data fields recorded, including procedure type, cost, jurisdiction, and clinical indication; and if such data is not collected in a structured manner, to outline the steps being taken to address this gap in repo…
Ken O'Flynn Written 14 Apr 2026 · to Health
2728. Deputy Ken O'Flynn asked the Minister for Health whether any formal, written eligibility criteria exist governing the approval of funding under the treatment abroad scheme for procedures not available within the State, including gender-related surgical procedures; if such criteria exist, to provide the date of their introduction, the authority under which they were approved, and the body responsible for maintai…
Ken O'Flynn Written 14 Apr 2026 · to Health
2729. Deputy Ken O'Flynn asked the Minister for Health the definition of “clinical necessity” applied in the context of approvals under the treatment abroad scheme; to specify whether this definition is standardised at national level or determined on a case-by-case basis by referring clinicians; and to confirm whether any national guidance, protocol, or decision-support framework exists to ensure consistency in the a…
Ken O'Flynn Written 14 Apr 2026 · to Health
2730. Deputy Ken O'Flynn asked the Minister for Health to detail the decision-making and approval process for applications under the treatment abroad scheme; to specify the roles of referring consultants, multidisciplinary teams, the HSE, and any central approval authority in determining whether funding is granted; and to confirm whether final approval decisions are subject to independent clinical or administrative r…